sureselect clinical research exome (cre) capture Search Results


target region sequencing coverage  (Sophia Genetics)
97
Sophia Genetics target region sequencing coverage
Verified CNVs in the four most frequently affected BC/OC predisposition genes in 4208 individuals according to phenotype. Each line represents a CNV spanning the corresponding <t>sequencing</t> targets in BRCA1 , BRCA2 , CHEK2 , and ATM . Deletions are shown in blue, and duplications are shown in red.
Target Region Sequencing Coverage, supplied by Sophia Genetics, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/sureselect+clinical+research+exome+(cre)+capture/Rare+disorders/pmc07794674-77-3-52
Average 97 stars, based on 1 article reviews
target region sequencing coverage - by Bioz Stars, 2026-10
97/100 stars
  Buy from Supplier
alamut visual version 2 15  (Sophia Genetics)
97
Sophia Genetics alamut visual version 2 15
Verified CNVs in the four most frequently affected BC/OC predisposition genes in 4208 individuals according to phenotype. Each line represents a CNV spanning the corresponding <t>sequencing</t> targets in BRCA1 , BRCA2 , CHEK2 , and ATM . Deletions are shown in blue, and duplications are shown in red.
Alamut Visual Version 2 15, supplied by Sophia Genetics, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/sureselect+clinical+research+exome+(cre)+capture/Alamut+Visual+Plus/pmc12215293-105-0-5
Average 97 stars, based on 1 article reviews
alamut visual version 2 15 - by Bioz Stars, 2026-10
97/100 stars
  Buy from Supplier
sophia hereditary cancer solutiontm hcs v1 1  (Sophia Genetics)
97
Sophia Genetics sophia hereditary cancer solutiontm hcs v1 1
Verified CNVs in the four most frequently affected BC/OC predisposition genes in 4208 individuals according to phenotype. Each line represents a CNV spanning the corresponding <t>sequencing</t> targets in BRCA1 , BRCA2 , CHEK2 , and ATM . Deletions are shown in blue, and duplications are shown in red.
Sophia Hereditary Cancer Solutiontm Hcs V1 1, supplied by Sophia Genetics, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/sureselect+clinical+research+exome+(cre)+capture/Hereditary+cancers/pm40596117-106-15-22
Average 97 stars, based on 1 article reviews
sophia hereditary cancer solutiontm hcs v1 1 - by Bioz Stars, 2026-10
97/100 stars
  Buy from Supplier
sureselect clinical research exome cre  (Sequenom)
86
Sequenom sureselect clinical research exome cre
Verified CNVs in the four most frequently affected BC/OC predisposition genes in 4208 individuals according to phenotype. Each line represents a CNV spanning the corresponding <t>sequencing</t> targets in BRCA1 , BRCA2 , CHEK2 , and ATM . Deletions are shown in blue, and duplications are shown in red.
Sureselect Clinical Research Exome Cre, supplied by Sequenom, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/sureselect+clinical+research+exome+(cre)+capture/clinical+exome+research+sureselect/pm41519853-217-12-11
Average 86 stars, based on 1 article reviews
sureselect clinical research exome cre - by Bioz Stars, 2026-10
86/100 stars
  Buy from Supplier
truseq dna pcr free library prep kit  (Illumina Inc)
96
Illumina Inc truseq dna pcr free library prep kit
Verified CNVs in the four most frequently affected BC/OC predisposition genes in 4208 individuals according to phenotype. Each line represents a CNV spanning the corresponding <t>sequencing</t> targets in BRCA1 , BRCA2 , CHEK2 , and ATM . Deletions are shown in blue, and duplications are shown in red.
Truseq Dna Pcr Free Library Prep Kit, supplied by Illumina Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/sureselect+clinical+research+exome+(cre)+capture/TruSeq+DNA+PCR-Free+Low+Throughput+Library+Prep+Kit/pmc07521702-116-9-8
Average 96 stars, based on 1 article reviews
truseq dna pcr free library prep kit - by Bioz Stars, 2026-10
96/100 stars
  Buy from Supplier
assays sureselect clinical research exome kits agilent  (Illumina Inc)
99
Illumina Inc assays sureselect clinical research exome kits agilent
Verified CNVs in the four most frequently affected BC/OC predisposition genes in 4208 individuals according to phenotype. Each line represents a CNV spanning the corresponding <t>sequencing</t> targets in BRCA1 , BRCA2 , CHEK2 , and ATM . Deletions are shown in blue, and duplications are shown in red.
Assays Sureselect Clinical Research Exome Kits Agilent, supplied by Illumina Inc, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/sureselect+clinical+research+exome+(cre)+capture/TruSeq+RNA+Library+Prep/pm33848478-261-229-251
Average 99 stars, based on 1 article reviews
assays sureselect clinical research exome kits agilent - by Bioz Stars, 2026-10
99/100 stars
  Buy from Supplier

Image Search Results


Verified CNVs in the four most frequently affected BC/OC predisposition genes in 4208 individuals according to phenotype. Each line represents a CNV spanning the corresponding sequencing targets in BRCA1 , BRCA2 , CHEK2 , and ATM . Deletions are shown in blue, and duplications are shown in red.

Journal: Cancers

Article Title: Performance of In Silico Prediction Tools for the Detection of Germline Copy Number Variations in Cancer Predisposition Genes in 4208 Female Index Patients with Familial Breast and Ovarian Cancer

doi: 10.3390/cancers13010118

Figure Lengend Snippet: Verified CNVs in the four most frequently affected BC/OC predisposition genes in 4208 individuals according to phenotype. Each line represents a CNV spanning the corresponding sequencing targets in BRCA1 , BRCA2 , CHEK2 , and ATM . Deletions are shown in blue, and duplications are shown in red.

Article Snippet: We suggest that target region sequencing coverage along with target region characteristics, such as GC content, length, and mappability, determined the accumulation of false positive CNV predictions (n = 57) and of classifications of target regions as either normal with medium confidence (n = 274) or undetermined (n = 131) by the Sophia Genetics DDM software.

Techniques: Sequencing